DFMB Data. Demographics. RedCAP-Assigned Record Number. Project ID

Size: px
Start display at page:

Download "DFMB Data. Demographics. RedCAP-Assigned Record Number. Project ID"

Transcription

1 DFMB Data Drug-Free Moms & Babies - New Sites Page 1 of 24 RedCAP-Assigned Record Number _ Project ID Demographics Is this the first time that the participant has been enrolled in DFMB? What is the project ID for the previous pregnancy? Date of Program Entry Maternal Age at Program Entry Gestational Age at Program Entry If you were not able to note gestational age at program entry was this because: (If this participant has participated in DFMB during a prior pregnancy, select "no". If this is the first pregnancy during which the participant participated, select "yes".) (If the patient's age at intake is not noted in the records from which you are abstracting data, enter "99".) (Enter a two-digit value between 2 and 42. If GA at program entry is not noted in the records from which you are abstracting data, enter "99".) The patient entered the program intending to become pregnant The patient entered the program after a birth outcome (including outcomes such as spontaneous abortion, etc.) The patient entered the program while pregnant, but the age was not recorded

2 Page 2 of 24 Race (Check All That Apply) race Ethnicity White Black Asian Native Hawaiian or Pacific Islander American Indian or Alaska Native Mixed (If race is not noted in the records from which you are abstracting data, check "".) n-hispanic Hispanic (If Hispanic ethnicity is not noted in the records from which you are abstracting data, check "t recorded".)

3 Page 3 of 24 County of Residence Barbour Berkeley Boone Braxton Brooke Cabell Calhoun Clay Doddridge Fayette Gilmer Grant Greenbrier Hampshire Hancock Hardy Harrison Jackson Jefferson Kanawha Lewis Lincoln Logan Marion Marshall Mason McDowell Mercer Mineral Mingo Monongalia Monroe Morgan Nicholas Ohio Pendleton Pleasants Pocahontas Preston Putnam Raleigh Randolph Ritchie Roane Summers Taylor Tucker Tyler Upshur Wayne Webster Wetzel Wirt Wood Wyoming Kentucky Maryland Ohio Pennsylvania Virginia (If the county of residence is not noted in the records from which you are abstracting data, select "".)

4 Page 4 of 24 Housing at time of program entry Number in household Insurance type Living in a permanent residence Living with friends or family Living in temporary housing (e.g., evicted, in process of moving, etc.) Residing in shelter Homeless (If housing at program entry is not noted in the records from which you are abstracting data, check "".) (Enter the number of people with whom the patient lived upon entry into the DFMB program, INCLUDING her. If the number of household residents is not noted in the records from which you are abstracting data, enter "99".) Private Medicaid Self-pay (If insurance type is not noted in the records from which you are abstracting data, check "t recorded".) type of insurance Income level at time of program entry Less than $15,000 (< $15,000), Less than $25,000 ($15,000 < = income < $25,000), Less than $35,000 ($25,000 < = income < $35,000), Less than $50,000 ($35,000 < = income < $50,000), Less than $75,000 ($50,000 < = income < $75,000), More than $75,000 (>= $75,000) (If income is not noted in the records from which you are abstracting data, check "".) Education level at time of program entry Employment at time of program entry Never attended school Some elementary school Some high school High school diploma or GED Technical training after high school Some college College graduate Graduate school (If education level is not noted in the records from which you are abstracting data, check "t recorded".) t currently employed Employed part-time Employed full-time (If employment at program entry is not noted in the records from which you are abstracting data, check "".)

5 Page 5 of 24 Marital status Cohabitation Married Separated Divorced Widowed Never married (If marital status is not noted in the records from which you are abstracting data, check "t recorded".) t cohabitating Cohabitating t reported (Was the patient cohabitating with a partner at the time she entered the DFMB program? The definition of cohabitation is a living arrangement in which an unmarried couple lives together in a long-term relationship that resembles a marriage.) Pregnancy Characteristics Gestational Age when Prenatal Care Initiated Was this a planned pregnancy? Is the participant intending to breastfeed at program entry? (Enter a two-digit value between 2 and 42. If GA at PNC initiation is not noted in the records from which you are abstracting data, enter 99.) Gs & Ps (Gravidity & Parity) Gravidity - G: Number of pregnancies Parity - T: Number of term births Parity - P: Number of preterm births Parity - A: Number of abortions Parity - L: Number of living children (Enter the total number of pregnancies, including the present one.) (Remember to include multiples such as twins as two fetuses/infants when entering parity data.) (Remember to include multiples such as twins as two fetuses/infants when entering parity data.) (Enter total number of spontaneous (miscarriages), therapeutic and elective abortions. Remember to include multiples such as twins as two fetuses/infants when entering parity data.) (Remember to include multiples such as twins as two fetuses/infants when entering parity data.)

6 Page 6 of 24 Pregnancy Complications During PREVIOUS Pregnancies Previous Pre-Term Birth Previous Cesarean Section Previous Pregnancy-Induced Hypertension (PIH) or Preclampsia Previous Abnormal Genetics Screen (unknown) Previous Stillbirth Previous Abdominal Surgery Previous Opioid Abuse Treatment Previous Macrosomia Previous Intrauterine Growth Restriction Gestational Diabetes During Previous Pregnancy Previous Placental Abruption Previous Ectopic Pregnancy Obesity During Previous Pregnancy Hepatitis B + During Previous Pregnancy Hepatitis C + During Previous Pregnancy Group B Strep + During Previous Pregnancy Pyelonephritis During Previous Pregnancy Previous Placental Previa Cervical Incompetence During Previous Pregnancy

7 Page 7 of 24 Pregnancy Complications During THIS Pregnancy Abnormal Genetics Screen Abdominal Surgery Cervical Incompetence Ectopic Pregnancy Gestational Diabetes Group B Strep + Hepatitis B + Hepatitis C + Intrauterine Growth Restriction Macrosomia Obesity Placental Abruption Placental Previa Pregnancy-Induced Hypertension (PIH) or Preclampsia (unknown) Pyelonephritis Was there any other pre-existing medical condition that affected the pregnancy? (e.g., Type II diabetes, hypertension) What pre-existing medical condition? (unknown) Prescription Medications Taken At Time of Pregnancy. In this section, note all of the prescription drugs of which you are aware that the patient was taking AT THE TIME at which she became pregnant (or found out she was pregnant). During pregnancy prescription drugs and non-prescription use are asked later! Selective Serotonin Re-uptake Inhibitors (SSRIs), by prescription Anti-Depressants Benzodiazepines Sleep Aids (Misc Sedatives/Hypnotics)

8 Page 8 of 24 Anti-convulsants Opioids for pain relief Opioids for medication assisted treatment (non-opioid) Pain Relievers Antipsychotic drugs Smoking Cessation Drugs Smoking Cessation Products Prescription Medications Used During THIS Pregnancy. In this section, note all of the drugs of which you are aware that the participant was prescribed DURING her pregnancy. n-prescription use is asked later! Selective Re-uptake Inhibitors (SSRIs), by prescription Anti-Depressants Benzodiazepines Sleep Aids (Misc Sedatives/Hypnotics) Anti-convulsants Opioids for pain relief Opioids for medication assisted treatment (non-opioid) Pain Relievers Antipsychotic drugs Smoking Cessation Drugs Substance Use History PRIOR to this pregnancy 1. Alcohol History of alcohol use? (Select "yes" if the participant has consumed alcohol.)

9 Page 9 of 24 How old was the patient when she first started drinking alcohol? Frequency of alcohol consumption (prior to pregnancy) Typical amount of alcohol consumed (prior to pregnancy) Has the patient ever been treated for alcohol abuse or dependence? Select all types of treatment for alcohol abuse or dependence that the patient has received. (If you are unable to abstract the age of initiation of alcohol use, enter "99".) 1-2 drinks 3-4 drinks 5-6 drinks 7-9 drinks 10 or more drinks (Enter the the number of drinks consumed on a typical day of drinking.) (unknown) In-patient Residential Sober living Intensive out-patient (IOP) Medication-assisted treatment out-patient Counseling Brief intervention (Select each type of treatment that the patient has received for an alcohol-use disorder. The categories may overlap, but still select all that apply.) 2. Tobacco History of tobacco use? How old was the participant when she first started using tobacco? Type used How frequently did the patient use tobacco? (If you are unable to abstract the age at which the participant initiated tobacco use, enter "99".) Cigarettes Smokeless E-cigarettes (such as pipes and cigars) (Check all that apply)

10 Page 10 of 24 How many cigarettes per day did the participant smoke? How many times per day did the patient use tobacco products other than cigarettes? Select the types of smoking cessation treatment that the patient has used prior to pregnancy. (One pack contains 20 cigarettes. If you are unable to abstract the number smoked per day prior to pregnancy, enter "99".) (If you are unable to abstract the number of times per that the participant used a tobacco product prior to pregnancy, enter "99".) Has never attempted to quit using tobacco Prescription (non-nicotine) medication Prescription nicotine replacement (patch, inhaler, nasal spray) Over-the-counter nicotine replacement (patch, gum, lozenge) Behavioral therapy Counseling Brief intervention On their own 3. Cannabis History of cannabis use? How old was the participant when she initiated cannabis use? Frequency of cannabis use (prior to pregnancy) Has the patient ever been in treatment for cannabis abuse? (If you are unable to abstract the age at which the participant initiated cannabis use, enter "99".) (unknown) 4. Stimulants History of stimulant use? How old was the participant when she initiated stimulant use? (Examples - Cocaine, Methamphetamine, Amphetamine (eg, MDMA, ecstasy), Methyphenidate, Synthetic cathinones (eg, bath salts)) (If you are unable to abstract the age at which the participant initiated stimulant use, enter "99".)

11 Page 11 of 24 Frequency of stimulant use (prior to pregnancy) Check all the specific stimulants used. Cocaine Methamphetamine Amphetamine (eg, MDMA, ecstasy) Methyphenidate Synthetic cathinones (eg, bath salts) List any other stimulants. Has the patient ever been in treatment for stimulant abuse? (unknown) 5. Hallucinogens History of hallucinogen use? How old was the participant when she initiated hallucinogen use? Frequency of hallucinogen use (prior to pregnancy) Check all the specific hallucinogens used. (Examples - LSD, PCP, Peyote, Psiloeybin (mushroom), Ketamine) (If you are unable to abstract the age at which the participant initiated hallucinogen use, enter "99".) LSD PCP Peyote Psiloeybin (mushroom) Ketamine DXM (triple C) List any other hallucinogens Has the patient ever been in treatment for hallucinogen abuse? (unknown)

12 Page 12 of Opioids/Narcotics History of opioid or narcotic use (for non-medical purposes defined as using more than prescribed, using more frequently than prescribed, or using that which was prescribed to someone else, i.e. diversion)? How old was the participant when she initiated opioid use? Frequency of opioid use (prior to pregnancy) Check all the specific opiods/narcotics used. (Examples - Heroin, Morphine, Meperidine (Demerol), Oxycodone (Perc, Oxy), Propaxyphene (Darvon), Codeine, Loperamide) (If you are unable to abstract the age at which the participant initiated opioid use, enter "99".) Heroin Morphine Methadone (Dolophone) Meperidine (Demerol) Oxycodone (Perc, Oxy, Roxi, endocet, targiniq) Propaxyphene (Darvon) Codeine and Hydrocodone (hydro, lorcet, lortab, norco, vicodin) Oxymorphone (opana) Anti-diarrheal (eg, Imodium, Lomotil, paregoric) Buprenorphine (Suboxone) synthetic opiods (eg, tramadol) Fentanyl (Hysingla, Zohydro) List any other opiods/narcotics Has the patient ever been in treatment for opioid abuse? (unknown) 7. Depressants History of depressants use (not including alcohol or opiods), for non-medical purposes? Check all the depressants used. (Examples - barbiturats, benzodiazepines) Barbituates Benzodiazepine (xanax, valium, ativan, klonopin) depressants (quaaludes, sleep aids, skeletal muscle relaxants) List the other depressants used

13 Page 13 of 24 How old was the participant when she initiated use of this substance? Frequency of depressant substance use (prior to pregnancy) Has the patient ever been in treatment for abuse of this substance? (If you are unable to abstract the age at which the participant initiated opioid use, enter "99".) (unknown) 8. substance use History of other substance use (for non-medical purposes defined as using more than prescribed, using more frequently than prescribed, or using that which was prescribed to someone else, i.e. diversion)? (Examples - inhalants, steriods) List the other substances used How old was the participant when she initiated use of this substance? Frequency of other substance use (prior to pregnancy) Has the patient ever been in treatment for abuse of this substance? (If you are unable to abstract the age at which the participant initiated opioid use, enter "99".) (unknown) Substance Use During This Pregnancy 1. Alcohol Did the participant drink alcohol during pregnancy? Frequency of alcohol consumption during pregnancy

14 Page 14 of 24 Typical amount of alcohol consumed during pregnancy 1-2 drinks 3-4 drinks 5-6 drinks 7-9 drinks 10 or more drinks (Enter the the number of drinks consumed on a typical day of drinking.) 2. Tobacco Did the participant use tobacco during pregnancy? Type used during pregnancy How many cigarettes per day did the participant smoke during pregnancy? How many times per day did the patient use tobacco products other than cigarettes? (during pregnancy), Cigarettes Smokeless E-cigarettes (such as pipes and cigars) (If you are unable to abstract the number smoked per day prior to pregnancy, enter "99".) (If you are unable to abstract the number of times per that the participant used a tobacco product prior to pregnancy, enter "99".) 3. Cannabis Did the participant use cannabis during pregnancy? Frequency of cannabis use during pregnancy 4. Stimulants Did the participant use stimulants during pregnancy? (Examples - Cocaine, Methamphetamine, Amphetamine (eg, MDMA, ecstasy), Methyphenidate, Synthetic cathinones (eg, bath salts))

15 Page 15 of 24 Frequency of stimulant use during pregnancy Check all the specific stimulants used. Cocaine Methamphetamine Amphetamine (eg, MDMA, ecstasy) Methyphenidate Synthetic cathinones (eg, bath salts) List any other stimulants. 5. Hallucinogens Did the participant use hallucinogens during pregnancy? Frequency of hallucinogen use during pregnancy Check all the specific hallucinogens used. (Examples - LSD, PCP, Peyote, Psiloeybin (mushroom), Ketamine) LSD PCP Peyote Psiloeybin (mushroom) Ketamine DXM (triple C) List the other hallucinogens used. 6. Opioids/Narcotics Did the participant use opioids or narcotics during pregnancy? (for non-medical purposes defined as using more than prescribed, using more frequently than prescribed, or using that which was prescribed to someone else, i.e. diversion)? Frequency of opioid/narcotics use during pregnancy (Examples - Heroin, Morphine, Meperidine (Demerol), Oxycodone (Perc, Oxy), Propaxyphene (Darvon), Codeine, Loperamide)

16 Page 16 of 24 Check all the specific opiods/narcotics used. Heroin Morphine Methadone (Dolophone) Meperidine (Demerol) Oxycodone (Perc, Oxy, Roxi, endocet, targiniq) Propaxyphene (Darvon) Codeine and Hydrocodone (hydro, lorcet, lortab, norco, vicodin) Oxymorphone (opana) Anti-diarrheal (eg, Imodium, Lomotil, paregoric) Buprenorphine (Suboxone) synthetic opiods (eg, tramadol) Fentanyl (Hysingla, Zohydro) List the other opiods used. 7. Depressants Did the participant use depressants (not including alcohol/opiods) during pregnancy? (for non-medical purposes defined as using more than prescribed, using more frequently than prescribed, or using that which was prescribed to someone else, i.e. diversion)? Frequency of depressants use during pregnancy Check all the specific depressants used. (Examples - barbiturats, benzodiazepines) Barbituates Benzodiazepine (xanax, valium, ativan, klonopin) depressants (quaaludes, sleep aids, skeletal muscle relaxants) List the other depressants used. 8. substance use Did the participant use other substances not previously listed during pregnancy? List the specific other substances used during pregnancy (Examples - inhalants, steriods)

17 Page 17 of 24 Frequency of other substances used during pregnancy Substance Abuse Treatment After Program Entry Is the participant enrolled in a substance abuse treatment program? What is the treatment program for? Select all types of treatment that the patient received DURING pregnancy. Currently participating in drug recovery and/or maintenance program? Current substance use self-reported (before testing) Maintenance medication Type of maintenance medication Drug testing method Drugs Alcohol Both In-patient Residential Sober living Intensive out-patient (IOP) Medication-assisted treatment out-patient Counseling Brief intervention (Select each type of treatment that the patient has received for an alcohol-use disorder. The categories may overlap, but still select all that apply.) Alcohol Tobacco Cannabis Stimulant Hallucinogens Opiods/Narcotics Depressants Methadone (Dolophine, Methadose) Buprenorphine (Subutex, Suboxone) Naltrexone (Depade, Revia) /unknown Urine drug screen /

18 Page 18 of 24 Positive drug screens t positive Positive for prescribed drugs only Positive for non-prescribed drugs t tested/ During 1st trimester During 2nd trimester During 3rd trimester At delivery After delivery to 6 weeks postpartum 7 weeks to 6 months postpartum 7 months to 9 months postpartum 10 months to 12 months postpartum 13 months to 24 months postpartum Referred to other treatment Referred to other treatment program? Referred program Inpatient or outpatient? Inpatient Outpatient Both Types of treatment during the program Please check the types of treatment during the program Indiviudal counseling Group counseling Prenatal education Postpartum education Recovering coach session Peer support Individual counseling Number of sessions the participant attended for individual counseling: Typical duration in minutes:

19 Page 19 of 24 Group counseling Number of sessions: Typical duration in minutes: Prenatal Number of prenatal visits Number of prenatal education sessions (These should be considered independent of group or individual counseling) Typical duration in minutes: Postpartum Number of postpartum education sessions: (These should be considered independent of group or individual counseling) Typical duration in minutes: Recovery coach sessions: 1. In Person: Number of in person recovery coach sessions (can include home or clinic visits): Typical duration in minutes: 2. Phone: Number of phone recovery coach sessions: Typical duration in minutes:

20 Page 20 of Text/Messages Number of text/message sessions (ie, about same topic): Typical quality of text/message Low quality (ie, no response from participant) Medium quality (eg, some response) High quality interactions 4. services not listed (eg, transportation) Referrals made to the following programs or services: t made Information given about program but no referral or use of services Referral made, services not used or unknown use Services accessed AA or NA Birth to Three Childcare CHIP or Insurance (e.g., ACA) CPS Criminal Justice or Legal Services Dental or Oral Health Services Domestic Violence Services Educational / Vocational Training Emergency Services (e.g., food, clothing) Family Planning Housing Job Training Mental Health Services (external to DFMB) Postpartum Medical Appointments for the Patient Public Assistance Religious Support Services Respite Care

21 Page 21 of 24 Right From the Start (or other home visitation program) Transportation WIC Services t Already Mentioned Specify Services to Which Patient Was Referred Program and Birth Outcomes Did the patient leave the program prematurely? How long did the patient remained engaged with the Drug-Free Moms & Babies program? How long did the patient remained engaged with the DFMB program? Why didn't the patient complete the program? Why was the patient lost to follow-up? What was the birth outcome for this pregnancy? If twins/multiples, choose all that apply What was the method of delivery for this birth? (completed the program) (Enter whether the patient completed the program.) Until delivery only Two full years postpartum (For patients that completed the program, please select whether they stayed until delivery or the full 2 years postpartum. Multiple answers may be selected for purposes of updating records.) Prior to delivery Until delivery only After delivery but before 6 months postpartum Between 6 months and 1 year post postpartum Between 1 year and 18 months postpartum Between 18 months and 2 years postpartum (For patients that left the program prematurely, please answer the time at which they left) Discharged due to noncompliance Lost to follow-up, i.e. dropped out of the program Referred to a higher level of care Re-entered program, new pregnancy (Enter the reason why the patient did not complete the DFMB program.) Personal preference Moved out of the program area Incarcerated / (Enter the reason why the patient dropped out of the program.) Live, term birth Live, preterm birth Stillborn Termination (Enter "Termination" for pregnancies that ended early due to abortion and "" if the birth outcome is not noted in the record from which you are abstracting these data.) C-section Vaginal

22 Page 22 of 24 What type of termination occurred? At what gestational age did the termination occur? How many weeks gestation was the pregnancy at delivery? Were there twins/multiples for this birth? What was the infant's birthweight in pounds and ounces? What was the infant's birth length in inches? What was the second infant's birthweight in pounds and ounces? What was the second infant's birth length in inches? What was the infant's sex at birth? What was the second infant's sex at birth? What was the infant's APGAR score at five minutes? What was the second infant's APGAR score at five minutes? What were the results of the cord tissue testing? If positive for drug exposure, were ONLY prescribed medications found in the results? Spontaneous abortion (miscarriage) Elective abortion Therapeutic abortion (elective abortion for medical reason) (Enter "99" if the gestational age at which the termination occurred was unknown.) (Enter "99" if unknown) (Enter "99" if unknown) (Enter "99" if unknown) (Enter "99" if unknown) (Enter "99" if unknown) Female Male Female Male (Enter the APGAR score assigned to the infant five minutes after birth. If this information is unknown, enter "99".) (Enter the APGAR score assigned to the infant five minutes after birth. If this information is unknown, enter "99".) t positive for drug exposure Positive for drug exposure or not available, prescribed only, prescribed AND other drugs, other drugs only

23 Page 23 of 24 For which drugs did the cord tissue screen positive? Specify other drugs. Was the infant admitted to a neonatal intensive care unit (NICU)? What was the length of stay in the NICU? After the infant was discharged from the hospital, was he or she readmitted? Was the infant diagnosed with neonatal abstinence syndrome (NAS)? Was the infant treated for NAS? (Check all that apply.) With what was the infant treated (for NAS)? Specify the other treatment. Was the infant breastfed after birth? Was the mother given the opportunity to breastfeed before leaving the hospital? Alcohol Amphetamines (amphetamine, MDA, MDEA, MDMA, methamphetamine) Barbiturates (amobarbital, butalbital, pentobarbital, phenobarbital, secobarbital) Benzodiazepines (alprazolam, diazepam, midazolam, nordiazepam, oxazepam, temazepam) Buprenorphine Cannabinoids (carboxy-thc) Cocaine (benzoylecgonine) Meperidine (meperidine, normeperidine) Methadone (EDDP, methadone) Opiates (6-MAM, meconin, codeine, hydrocodone, hydromorphone, morphine) Oxycodone (oxycodone, oxymorphone) Phencyclidine (phencyclindine) (PCP) Propoxyphene (propoxyphene, norpropoxyphene) Tramadol (tramadol) (Check each drug for which the cord testing results came back positive.) (Enter the number of days that the infant was admitted to the NICU. If these data are not noted in the records from which you are abstracting this information, enter "999".), therapeutic, pharmacologic (Indicate whether the infant received non-pharmacologic and/or pharmacologic treatment for NAS.) Morphine Methadone

24 Page 24 of 24 Was the infant sent home with mother or discharged from hospital to the mother's care?

PUBLIC SCHOOL SUPPORT PROGRAM AVERAGE STATE FUNDED SALARY FOR PROFESSIONAL EDUCATORS FINAL COMPS

PUBLIC SCHOOL SUPPORT PROGRAM AVERAGE STATE FUNDED SALARY FOR PROFESSIONAL EDUCATORS FINAL COMPS PUBLIC SCHOOL SUPPORT PROGRAM AVERAGE STATE FUNDED SALARY FOR PROFESSIONAL EDUCATORS 2018-19 FINAL COMPS Basic Equity County Salary Salary Total Barbour 43,055.50 3,674.06 46,729.56 Berkeley 41,428.42

More information

Opiate Abuse and the Growing Impact on Maternal and Child Health in West Virginia. Overview

Opiate Abuse and the Growing Impact on Maternal and Child Health in West Virginia. Overview Opiate Abuse and the Growing Impact on Maternal and Child Health in West Virginia Christina, Director Office of Maternal, Child and Family Health Bureau for Public Health October 23, 2017 Overview Describe

More information

CHAPTER 2: HEALTH CARE ACCESS

CHAPTER 2: HEALTH CARE ACCESS CHAPTER 2: HEALTH CARE ACCESS No Health Care Coverage (among Adults 18 to 64) in 2006 Definition Responding No to the following question: Do you have any kind of health care coverage, including health

More information

CHAPTER 11: ALCOHOL CONSUMPTION

CHAPTER 11: ALCOHOL CONSUMPTION CHAPTER 11: ALCOHOL CONSUMPTION Heavy Drinking: Defined as consumption of more than two drinks per day for men and more than one drink per day for women during the past one month. 7 State Prevalence 3.1%

More information

CHAPTER 9: ALCOHOL CONSUMPTION

CHAPTER 9: ALCOHOL CONSUMPTION CHAPTER 9: ALCOHOL CONSUMPTION Binge Drinking in 2004 and 2005 Definition Consumption of five or more alcoholic drinks on one or more occasions during the past one month. Prevalence WV: 9.7% (95% CI: 8.4-11.1)

More information

CHAPTER 6: TOBACCO USE

CHAPTER 6: TOBACCO USE CHAPTER 6: TOBACCO USE Current Cigarette Smoking in 2006 Smoking at least 100 cigarettes in one s lifetime and currently smoking every day or some days. Prevalence WV: 25.7% (95% CI: 24.0-27.5) in 2006.

More information

FINAL COMPUTATIONS - HB 4588 PUBLIC SCHOOL SUPPORT PROGRAM FOR THE YEAR

FINAL COMPUTATIONS - HB 4588 PUBLIC SCHOOL SUPPORT PROGRAM FOR THE YEAR Step 1a Step 1b Step 1 Step 1 Step 1 Basic Salary Increment Basic Equity Total Allowance For Principals Allowance Allowance Allowance Professional & Assistant Professional Professional Professional Educators

More information

FINAL COMPUTATIONS PUBLIC SCHOOL SUPPORT PROGRAM FOR THE YEAR

FINAL COMPUTATIONS PUBLIC SCHOOL SUPPORT PROGRAM FOR THE YEAR Step 1a Step 1b Step 1 Step 1 Step 1 Basic Salary Increment Basic Equity Total Allowance For Principals Allowance Allowance Allowance Professional & Assistant Professional Professional Professional Educators

More information

The overall data goal for WVAEPP and its partners is to maintain and improve the measurement of the burden of asthma in West Virginia.

The overall data goal for WVAEPP and its partners is to maintain and improve the measurement of the burden of asthma in West Virginia. The overall data goal for WVAEPP and its partners is to maintain and improve the measurement of the burden of asthma in West Virginia. This surveillance information will be used for program planning, education,

More information

RD INSTRUCTION 1980-D, EXHIBIT C PAGE 308 GUARANTEED HOUSING PROGRAM INCOME LIMITS

RD INSTRUCTION 1980-D, EXHIBIT C PAGE 308 GUARANTEED HOUSING PROGRAM INCOME LIMITS RD INSTRUCTION 1980-D, EXHIBIT C PAGE 308 Charleston, WV MSA Boone County, WV HUD Metro FMR Area VERY LOW INCOME 17500 20000 22500 25000 27000 29000 31000 33000 LOW INCOME 28000 32000 36000 40000 43200

More information

1 PERSON 2 PERSON 3 PERSON 4 PERSON 5 PERSON 6 PERSON 7 PERSON 8 PERSON

1 PERSON 2 PERSON 3 PERSON 4 PERSON 5 PERSON 6 PERSON 7 PERSON 8 PERSON Fayette County, WV HUD Metro FMR Area Raleigh County, WV HUD Metro FMR Area Charleston, WV HUD Metro FMR Area 30% LIMITS 12250 14000 15750 17450 18850 20250 21650 23050 VERY LOW INCOME 20400 23300 26200

More information

State Data Report. ASTHO Breast Cancer Learning Community: Using Data to Address Disparities in Breast Cancer Mortality at the State Level

State Data Report. ASTHO Breast Cancer Learning Community: Using Data to Address Disparities in Breast Cancer Mortality at the State Level State Data Report STATE HEALTH DEPARTMENT NAME: WV Bureau for Public Health Dr. Rahul Gupta, Commissioner ASTHO Breast Cancer Learning Community: Using Data to Address Disparities in Breast Cancer Mortality

More information

2014 Rankings. West Virginia

2014 Rankings. West Virginia 2014 Rankings West Virginia INSIDE FRONT COVER INTENTIONALLY BLANK INTRODUCTION The County Health Rankings & Roadmaps program helps communities identify and implement solutions that make it easier for

More information

A System of Care Surrounding the Drug Exposed Neonate. Disclosures. Objectives 11/17/2015. I have no financial disclosures

A System of Care Surrounding the Drug Exposed Neonate. Disclosures. Objectives 11/17/2015. I have no financial disclosures A System of Care Surrounding the Drug Exposed Neonate Sean Loudin MD Disclosures I have no financial disclosures Objectives Discuss the epidemiology of Neonatal Abstinence Syndrome (NAS) both nationally

More information

TOBACCO IS KILLING (AND COSTING) US. A Report on Tobacco Use Rates, Smoking-Related Deaths, and Smoking-Related Health Care Costs in West Virginia

TOBACCO IS KILLING (AND COSTING) US. A Report on Tobacco Use Rates, Smoking-Related Deaths, and Smoking-Related Health Care Costs in West Virginia TOBACCO IS KILLING (AND COSTING) US A Report on Tobacco Use Rates, Smoking-Related Deaths, and Smoking-Related Health Care Costs in West Virginia Joe Manchin III Governor Martha Yeager Walker Secretary,

More information

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia NEW TESTS Please Note: Not all test codes assigned to each assay are listed in the table of contents. Please refer to the complete listing on the page numbers indicated. Test Code Test Name Effective Date

More information

PARTICIPANT GENERAL INFORMATION

PARTICIPANT GENERAL INFORMATION PARTICIPANT GENERAL INFORMATION Instructions: Please complete entire form (print) First name: Last Name: Other names used: Street address: City/State/Zip: County: Region: East TN Middle West Social Security

More information

People In Need Adult Intake Information Form (18 years old and up)

People In Need Adult Intake Information Form (18 years old and up) People In Need Adult Intake Information Form (18 years old and up) Date: Name: Client Case # Sex: Date of Birth: Social Security Number: - - Home Address: Work Address: Employer: Occupation: Referred by:

More information

The Caring Center of Wichita LLC. General Information Client Name:

The Caring Center of Wichita LLC. General Information Client Name: PERSONAL & SUBSTANCE ABUSE HISTORY Biological / Psychological / Social Assessment Assessors Name: Date of Assessment: General Information Client Name: Maiden (If Applicable): Date of Birth: Home Phone:

More information

Report of 2002 Local Health Department Surveillance Assessment. Infectious Disease Epidemiology Program

Report of 2002 Local Health Department Surveillance Assessment. Infectious Disease Epidemiology Program Report of 2002 Local Health Department Surveillance Assessment Infectious Disease Epidemiology Program Division of Surveillance and Disease Control West Virginia Bureau for Public Health 350 Capitol Street,

More information

Outlook and Outcomes Fiscal Year 2011

Outlook and Outcomes Fiscal Year 2011 Baltimore Substance Abuse Systems, Inc. Outlook and Outcomes Fiscal Year 2011 Baltimore City Greg Warren, President Compiled July 2012 BSAS Outlook and Outcomes is the first edition of a planned annual

More information

WEST VIRGINIA COMMUNITY EVALUATION

WEST VIRGINIA COMMUNITY EVALUATION WEST VIRGINIA COMMUNITY TRANSFORMATION GRANT 2011-14 EVALUATION WVU Health Research Center, WVU School of Public Health Christiaan Abildso, PhD, MPH Jessica Coffman, MA Louise Moore, RN Susan Crayne December,

More information

Becky Nickol, NCC, LMHC Licensed Mental Health Counselor, MH Wood Lake Drive Maitland, Florida

Becky Nickol, NCC, LMHC Licensed Mental Health Counselor, MH Wood Lake Drive Maitland, Florida Becky Nickol, NCC, LMHC Licensed Mental Health Counselor, MH 8569 240 Wood Lake Drive Maitland, Florida 32751 407-831-7783 becky@beckynickol.com Adult Biopsychosocial Assessment General Information Date:

More information

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D. Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals

More information

The Drug Testing Process. Employer or Practice

The Drug Testing Process. Employer or Practice Disclosures Clinical Professor, Jefferson Medical College BOD MROCC [Medical Review Officer Certification Council] BOD National Sleep Foundation BOD POEMS [Pennsylvania Occupational & Environmental Medicine

More information

Today s Objectives. Working together for healthier mothers and babies

Today s Objectives. Working together for healthier mothers and babies Today s Objectives Examine Substance Use in Pregnancy and subsequent Neonatal Abstinence Syndrome prevalence Discuss identification and treatment for substance exposed infants vs those diagnosed with Neonatal

More information

SEERED COMMOTION CONTACT PREPARE GO COMPLETE. Here s how to participate: Material examples:

SEERED COMMOTION CONTACT PREPARE GO COMPLETE. Here s how to participate: Material examples: It is illegal to sell tobacco products to anyone under the age of 18. Educate retailers and help put a stop to underage tobacco sales by supporting the SEE RED? initiative. Here s how to participate: CONTACT

More information

CalOMS Discharge Form Instructions

CalOMS Discharge Form Instructions Form Instructions REQUIRED FORM: The Discharge form is a required document in the client file WHEN: This form will be created at the end of the client s treatment episode and completed in SanWITS by the

More information

NIDA Quick Screen V1.0F1

NIDA Quick Screen V1.0F1 NIDA Quick Screen V1.0F1 Name:... Sex ( ) F ( ) M Age... Interviewer... Date.../.../... Introduction (Please read to patient) Hi, I m, nice to meet you. If it s okay with you, I d like to ask you a few

More information

Physical Issues: Emotional Issues: Legal Issues:

Physical Issues: Emotional Issues: Legal Issues: Men s Facility 1119 Ferry Street Lafayette, IN 47901 Phone: (765) 807-0009 Fax: (765) 807-0030 Hope Apartments 920 N 11th St. Lafayette, IN 47904 Phone: (765) 742-3246 Fax: (765) 269-9110 APPLICATION FOR

More information

Laboratory Service Report

Laboratory Service Report 4 05/25/19 Client C702884-DLP ROCHESTER Amphetamines, Confirmation Positive Confirmed POSITIVE by LC-S/S for the following: Amphetamine = 52 ethamphetamine = 124 ethamphetamine exists in the d- and l-isomeric

More information

Wheaton Franciscan Healthcare

Wheaton Franciscan Healthcare Today s Date Wheaton Franciscan Healthcare PATIENT AND FAMILY MEDICAL HISTORY Patient s Name: Marital Status: r Married r Single r Divorced r Widowed r Other Date of Birth: Gender: r Male r Female Religion:

More information

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016)

ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016) ChemaTox Blood Drug Testing Matrix (Updated May 24th, 2016) Email: DREtox@chematox.com; Phone: (303)440-4500 Always identify any medications/drugs the suspect states they have taken, or that you suspect

More information

Pinkston Psychology, LLC Ph. (318) Fx. (318) Completed this form Patient Spouse Parent Other

Pinkston Psychology, LLC Ph. (318) Fx. (318) Completed this form Patient Spouse Parent Other Pinkston Psychology, LLC Ph. (318) 553-5099 paula@pinkstonpsychology.com Fx. (318) 553-5338 ADULT HISTORY FORM Date Completed this form Patient Spouse Parent Other Patient s Name Date of Birth Age Sex

More information

Drug Testing Basics. by Erowid

Drug Testing Basics. by Erowid Drug Testing Basics by Erowid INDEX 1. What do they Test for? 2. Test Types 3. Test Sensitivity 4. Detection Periods WHAT DO THEY TEST FOR? The first thing to know about drug testing is what the standard

More information

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX

Pain Management and Compliance Toxicology. Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Pain Management and Compliance Toxicology Greg Jellick, MSFS, D-ABFT-FT Technical Director Quality Toxicology San Antonio, TX Prescription Drug Abuse: A National Problem Prescription drug abuse is a growing

More information

NIDA-Modified ASSIST Prescreen V1.0 1

NIDA-Modified ASSIST Prescreen V1.0 1 NIDA-Modified ASSIST Prescreen V1.0 1 F Name:... Sex ( ) F ( ) M Age... Interviewer... Date.../.../... Introduction (Please read to patient) Hi, I m, nice to meet you. If it s okay with you, I d like to

More information

Urine Drug Testing Methods 3-5

Urine Drug Testing Methods 3-5 Urine Drug Testing Methods 3-5 Type of Test Logistics Pearls Initial Screening Test: Immunoassay Confirmatory Test: Gas chromatography-mass spectrometry (GCMS) + or Liquid chromatography-mass spectrometry

More information

James Keresztury, ACSW, MBA

James Keresztury, ACSW, MBA James Keresztury, ACSW, MBA I have no actual or potential conflict of interest in relation to this program/presentation. Presentation Goals Increase awareness of cancer burden in WV. Promote awareness

More information

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082

Alcohol. Ethanol Highlands Parkway, Suite 100 Smyrna, GA 30082 Alcohol The alcohol of interest is ethanol. Ethanol has a sedative effect in the brain. Ethanol intoxication symptoms include blurred vision, slurred speech, poor coordination and difficulty thinking depending

More information

Prescription Drugs MODULE 5 ALLIED TRADES ASSISTANCE PROGRAM. Preventative Education: Substance Use Disorder

Prescription Drugs MODULE 5 ALLIED TRADES ASSISTANCE PROGRAM. Preventative Education: Substance Use Disorder Prescription Drugs MODULE 5 ALLIED TRADES ASSISTANCE PROGRAM Preventative Education: Substance Use Disorder Misuse of prescription pain relievers is, after marijuana use, the second most common form of

More information

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC

Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Maternal-fetal Opiate Medical Home (MOMH) Jocelyn Davis DNP,CNM, RN, CEFMM Karen Frantz BSN, RNC Objectives 1. Discuss the effects of opiate addiction on mothers and infants. 2. Discuss a Medical Home

More information

HAVEN WOMEN S PROGRAM APPLICATION

HAVEN WOMEN S PROGRAM APPLICATION Hello, Thank you for your interest in the Haven of Rest Women s Ministry. We are a long-term (approximately 12 months), residential discipleship program for women with life-dominating issues. Our ultimate

More information

Urine Opioid Dependency Panel (UODP) 1

Urine Opioid Dependency Panel (UODP) 1 Drug Testing Panels Urine Opioid Dependency Panel (UODP) 1 Amphetamines Amphetamine Methamphetamine Methylenedioxyamphetamine Adderall, Dexedrine, Vyvanse, Lisdexamfetamine (Speed, Bennies, Crystal Meth,

More information

Appendix A. Socio-demographic Characteristics of Survey Respondents Compared to Current Population Survey (2013) Data

Appendix A. Socio-demographic Characteristics of Survey Respondents Compared to Current Population Survey (2013) Data Data Supplement for Kennedy-Hendricks et al. (10.1176/appi.ps.201600056) Appendix A. Socio-demographic Characteristics of Survey Respondents Compared to Current Population Survey (2013) Data Un-weighted

More information

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions September 2016 HCMC Toxicology Transition: Additional information and Frequently Asked Questions Many clinicians have asked for more information about the Urine Drug Compliance Analysis (LAB8742) switch

More information

Urine drug testing it s not always crystal clear

Urine drug testing it s not always crystal clear Urine drug testing it s not always crystal clear Kirk Moberg, MD, PhD, FASAM Executive Medical Director, UnityPoint Health Illinois Institute for Addiction Recovery Clinical Professor of Internal Medicine

More information

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Medication Assisted Treatment MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Opioid Drugs Opium Morphine Heroin Codeine Oxycodone Roxycodone Oxycontin

More information

NIDA-Modified ASSIST - Prescreen V1.0*

NIDA-Modified ASSIST - Prescreen V1.0* NIDA-Modified ASSIST Assessment Instrument [1] NIDA-Modified ASSIST - Prescreen V1.0* *This screening tool was adapted from the WHO Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) Version

More information

TELEPHONE SCREENING DEMOGRAPHIC INFO

TELEPHONE SCREENING DEMOGRAPHIC INFO TELEPHONE SCREENING Provider Name: Provider Signature: Date: How did you hear about the hotline? DEMOGRAPHIC INFO 1 = Spouse 2 = Friend 3 = Medical Provider 4 = Flyer 5 = Parent 6 = State Hotline 7 = Physician

More information

Prescription Drug Monitoring Reference Guide: 2017

Prescription Drug Monitoring Reference Guide: 2017 Prescription Drug Monitoring Reference Guide: 2017 Prescription Drug Monitoring Test Codes Test Codes Drug/Drug Class P P,D,M P,D D,M D Alcohol Metabolites 90079 16910 92142 16217 Amphetamines 92222 70245

More information

PERSONAL HISTORY NAME TODAY S DATE LAST FIRST MI LIST ANY ADDITIONAL NAMES USED: ADDRESS PHONE (STREET) (CITY) (STATE) (COUNTY) (ZIP)

PERSONAL HISTORY NAME TODAY S DATE LAST FIRST MI LIST ANY ADDITIONAL NAMES USED: ADDRESS PHONE (STREET) (CITY) (STATE) (COUNTY) (ZIP) PERSONAL HISTORY PERSONAL INFORMATION: NAME TODAY S DATE LAST FIRST MI LIST ANY ADDITIONAL NAMES USED: ADDRESS_ PHONE (STREET) (CITY) (STATE) (COUNTY) (ZIP) AGE: DATE OF BIRTH: SOCIAL SECURITY #: RACE:

More information

CalOMS Admission. Page 1 of 6

CalOMS Admission. Page 1 of 6 CalOMS Form All fields (unless labeled optional) must be completed CalOMS Admission Client Profile Client First Name Provider Client ID (optional) Client Last Name SSN - - Middle Initial Drivers License

More information

Easy Does It, Inc. Housing Application

Easy Does It, Inc. Housing Application Easy Does It, Inc. Housing Application Thank you for applying to Easy Does It, Inc. ( EDI ) a non-profit charitable organization dedicated to improving the quality of life of individuals and families recovering

More information

EVALUATION OF THE LANCASTER COUNTY ADULT DRUG COURT YEAR 3

EVALUATION OF THE LANCASTER COUNTY ADULT DRUG COURT YEAR 3 EVALUATION OF THE LANCASTER COUNTY ADULT DRUG COURT YEAR 3 September 30, 2013 Prepared by: The Public Policy Center University of Nebraska 215 Centennial Mall South, Suite 401 Lincoln, NE 68588 0228 Phone:

More information

CMBHS Clinical Management of Behavioral Health Services

CMBHS Clinical Management of Behavioral Health Services Client: CMBHS Clinical Management of Behavioral Health Services Case Management AST022 Assessment Information Assessment Number Assessment Date Assessment Type Contact Type Assessment Site Referred By

More information

West Virginia Tobacco Quitline Evaluation WEST VIRGINIA PREVENTION RESEARCH CENTER

West Virginia Tobacco Quitline Evaluation WEST VIRGINIA PREVENTION RESEARCH CENTER West Virginia Tobacco Quitline Evaluation WEST VIRGINIA PREVENTION RESEARCH CENTER West Virginia Tobacco Quitline Evaluation Valerie Frey-McClung Megan Gallaway Evaluation Lead Dustin Long Leesa Prendergast

More information

The Role of Opioid Overdoses in Confirmed Maternal Deaths,

The Role of Opioid Overdoses in Confirmed Maternal Deaths, The Role of Opioid Overdoses in Confirmed Maternal Deaths, 2012-2015 Introduction The Department of State Health Services (DSHS) conducted an analysis of maternal deaths resulting from drug overdoses from

More information

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) 1 Policy #: 803 (PLH-803-02) Effective Date: NA Reviewed Date: 4/11/2008 Subject: URINE DRUG SCREENS Approved by: Laboratory Executive Director, Ed Hughes (electronic signature) Approved by: Laboratory

More information

Name: Date: Gender: Family and Social. Family Constellation

Name: Date: Gender: Family and Social. Family Constellation Name: Date: Gender: Age: Date of Birth: Race: Family and Social Family Constellation First Name Or Initials Parents (indicate biological or other): Age Gender Marital Status Occupation Education If deceased,

More information

PATIENT INTAKE: MEDICAL AND SOCIAL HISTORY (To be completed by patient)

PATIENT INTAKE: MEDICAL AND SOCIAL HISTORY (To be completed by patient) NAME: DOB: Today's date: PATIENT INTAKE: MEDICAL AND SOCIAL HISTORY (To be completed by patient) Use the opposite side of the page as necessary to complete your answers. Please print legibly. Patient Name

More information

Buprenorphine & Controlled Substance Treatment Agreement

Buprenorphine & Controlled Substance Treatment Agreement Buprenorphine & Controlled Substance Treatment Agreement I agree to accept the following treatment contract for buprenorphine office-based opioid addiction treatment: 1. I will keep my medication in a

More information

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine Reporting Title: Pain Clinic Drug Screen, CoC, U Performing Location: Rochester Specimen Requirements: Container/Tube: Chain-of-Custody Kit (Supply T282) containing the specimen containers, seals, and

More information

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J.

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D Director: David J. Drug Adherence Assessment Report Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - REPORTED MEDICATION DETECTED (PARENT DRUG AND/OR METABOLITE) REPORTED PRESCRIPTION FLAG ANTICIPATED

More information

Transitional, Intergenerational Group Residence Application. Texas ID# Primary Language: Address: City, State, Zip Code: Phone-home ( ) Phone-work ( )

Transitional, Intergenerational Group Residence Application. Texas ID# Primary Language: Address: City, State, Zip Code: Phone-home ( ) Phone-work ( ) PERSONAL/FAMILY INFORMATION Name Date Date of Birth / / SS # Gender Texas ID# Primary Language: Marital Status: Single Divorced Common Law Living Together Married & living with Spouse not living with Spouse

More information

Medication Assisted Treatment

Medication Assisted Treatment Meeting the Needs of Your Clients: Building Competencies in Mental Health and Addiction Services Medication Assisted Treatment November 5, 2018 In partnership with: House Keeping Because this is a webinar,

More information

LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching

LCMS-8050 Drugs of Abuse: 113 Analytes with Polarity Switching Liquid Chromatography Mass Spectrometry SSI-LCMS-8 LCMS-8 Drugs of Abuse: Analytes with Polarity Switching LCMS-8 Summary Seventy six analytes and their internal standards are described below. Multiple

More information

Colorado Health Network Medical Clinic

Colorado Health Network Medical Clinic Colorado Health Network Medical Clinic Intake for PrEP Patient Navigator: Admission Date: Intake Date: Client #: Referral Source: Regional Office: CONTACT INFORMATION: Client Legal Name: Proof of Legal

More information

Drug Abuse Trends Minneapolis/St. Paul, Minnesota

Drug Abuse Trends Minneapolis/St. Paul, Minnesota This document is made available electronically by the Minnesota Legislative Reference Library as part of an ongoing digital archiving project. http://www.leg.state.mn.us/lrl/lrl.asp Drug Abuse Trends Minneapolis/St.

More information

PATIENT INTAKE: MEDICAL HISTORY. Name. Address. Phone (W) (H) (C) DOB Age SS# Emergency Contact. Relationship to patient Phone

PATIENT INTAKE: MEDICAL HISTORY. Name. Address. Phone (W) (H) (C) DOB Age SS# Emergency Contact. Relationship to patient Phone PATIENT INTAKE: MEDICAL HISTORY Name Address Phone (W) (H) (C) DOB Age SS# Emergency Contact Relationship to patient Phone Primary care physician Phone Have you ever had an EKG? Y N Date Current or past

More information

RECOVERY APPLICATION The Foundry Ministries

RECOVERY APPLICATION The Foundry Ministries RECOVERY APPLICATION The Foundry Ministries PERSONAL FIRST NAME MIDDLE NAME LAST NAME LAST PHYSICAL STREET ADDRESS CITY STATE ZIP CELL EMAIL ADDRESS DEMOGRAPHICS GENDER ETHNICITY AGE MARITAL STATUS SINGLE

More information

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

Test Definition: PCDSO Pain Clinic Drug Screen, Urine Reporting Title: Pain Clinic Drug Screen, U Performing Location: Rochester Specimen Requirements: Collection Container/Tube: Plastic urine container Submission Container/Tube: Plastic, 60-mL urine bottle

More information

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital What Your Drug Test Really Means Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital Disclosure There are no relevant financial relationships with commercial interests associated.

More information

Transitional Housing Application

Transitional Housing Application Transitional Housing Application Applicant Information Name: Date of birth: SSN: ID Number: Current address: City: State: ZIP Code: Phone: Email: Name of Last Social Worker or Probation Officer:: Original

More information

5/15/2017. Neglect. Potpourri of Child Neglect: Drug-exposure, Failure to Thrive, Medical Care. Forms of Neglect

5/15/2017. Neglect. Potpourri of Child Neglect: Drug-exposure, Failure to Thrive, Medical Care. Forms of Neglect Potpourri of Child Neglect: Drug-exposure, Failure to Thrive, Medical Care Karen Farst, MD, MPH University of Arkansas for Medical Sciences, Department of Pediatrics Arkansas Children s Hospital, Team

More information

If so, when: Demographic Information Male Transgender Height: Weight: Massachusetts Resident? Primary Language: Are you currently homeless?

If so, when: Demographic Information Male Transgender Height: Weight: Massachusetts Resident? Primary Language: Are you currently homeless? Application Form rev. 9/09 Jeremiah's Inn P.O. Box 30035 1059 Main St., Worcester, MA 01603-0035 FAX 508.793.9568 Phone 508.755.6403 Last Name: Suffix: First Name: Middle Initial: Alias: Referral Information

More information

*IN10 BIOPSYCHOSOCIAL ASSESSMENT*

*IN10 BIOPSYCHOSOCIAL ASSESSMENT* BIOPSYCHOSOCIAL ASSESSMENT 224-008B page 1 of 5 / 06-14 Please complete this questionnaire and give it to your counselor on your first visit. This information will help your clinician gain an understanding

More information

PERINATAL TOBACCO USE

PERINATAL TOBACCO USE PERINATAL TOBACCO USE Child Fatality Task Force Meeting December 7, 2015 Erin McClain, MA, MPH You Quit, Two Quit, UNC Center for Maternal & Infant Health Percentage Women & Tobacco Use in NC 2 50 45 40

More information

Many drugs of abuse are illegal drugs. Possessing, using, buying, or selling these drugs is illegal for people of any age.

Many drugs of abuse are illegal drugs. Possessing, using, buying, or selling these drugs is illegal for people of any age. 1 Chapter 12 Section 1 Objectives List six ways illegal drug use can be dangerous. State five reasons a person might try illegal drugs. Identify the reason drug abuse is especially dangerous to teens.

More information

Physician s Reference for Urine and Blood Drug Testing and Interpretation

Physician s Reference for Urine and Blood Drug Testing and Interpretation Physician s Reference for Urine and Blood Drug Testing and Interpretation DETECTIMED PANEL Urine (test code 70195) Screen Confirmation Screen Confirmation Alcohol Ethanol Amphetamines Amphetamine Methamphetamine

More information

Substance Use and Misuse in the Military

Substance Use and Misuse in the Military Substance Use and Misuse in the Military Terry A. Adirim, M.D., M.P.H. Deputy Assistant Secretary of Defense for Health Services Policy and Oversight Health Affairs Department of Defense The Military Health

More information

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years

3703 Camino del Rio South 100-A San Diego, CA, Phone Fax CLIA# 05D years Drug Adherence Assessment Report CleanAssure TM (DRIED BLOOD SPOT): Detection Range see NOTES. Prescribed Medications: NO MEDICATION LIST PROVIDED CONSISTENT RESULTS - MEDICATION DETECTED (PARENT DRUG

More information

The Science and Practice of Perinatal Tobacco Use Cessation

The Science and Practice of Perinatal Tobacco Use Cessation 1 The Science and Practice of Perinatal Tobacco Use Cessation Erin McClain, MA, MPH Catherine Rohweder, DrPH Cathy Melvin, PhD, MPH erin_mcclain@unc.edu Prevention of Tobacco Use and Secondhand Smoke Exposure

More information

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population Adam S. Ptolemy 1, Colleen Murray 2, Edward Dunn 3,

More information

Anesthetics, Local a / or Anesthesia, Epidural a / or Anesthesia, Obstetrical a / or Pain, Postoperative a / or Postpartum Period a

Anesthetics, Local a / or Anesthesia, Epidural a / or Anesthesia, Obstetrical a / or Pain, Postoperative a / or Postpartum Period a Appendix 1. Literature Search Databases Years Search Terms Pubmed 01/1966 1. Analgesics, Opioid a / or Opioid-related Disorders a / PsycINFO EMBASE Cochrane 09/2016 or Heroin a / or Heroin Dependence a

More information

Prescription Opioids

Prescription Opioids What are prescription opioids? Prescription Opioids Opioids are a class of drugs naturally found in the opium poppy plant. Some prescription opioids are made from the plant directly, and others are made

More information

Disclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O.

Disclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O. Evolving Treads in Medication Assisted Treatment Christopher J Davis D.O. CAADC, FASAM Medical Director, The Ranch of Pennsylvania Medical Director, Pyramid Healthcare Diplomate of The American Board of

More information

NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE

NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE NEONATAL ABSTINENCE SYNDROME (NAS) AKA NEWBORN DRUG WITHDRAWAL:THE NEWARK EXPERIENCE Salma Ali MD, Debra Brendel RN, BSN, MSN and Ona Fofah MD Division of Neonatology and Newborn Medicine Department of

More information

CalOMS Admission Form Instructions

CalOMS Admission Form Instructions Form Instructions REQUIRED FORM: The Admission form is a required document in the client s file. Each participant s initial admission to the facility and any subsequent transfers or changes in service

More information

Methadone and Pregnancy

Methadone and Pregnancy Methadone and Pregnancy Methadone/Buprenorphine 101 Workshop, April 1, 2017 Charissa Patricelli, MD, CCFP, ABAM Clinical Associate Professor, Dept. of Family Practice UBC American Board of Addiction Medicine

More information

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use Report of the Government of: Reporting Year: Completed on (date): Please return completed questionnaire to: arq@unodc.org

More information

PATIENT IDENTIFICATION: Name: First Appointment Date: Birth Date: Address: City State Zip Home Phone #: Work #: Cell #: REFERRAL SOURCE: Referred By:

PATIENT IDENTIFICATION: Name: First Appointment Date: Birth Date: Address: City State Zip Home Phone #: Work #: Cell #: REFERRAL SOURCE: Referred By: Andrew E. Leifer, M.D., P.C. 1202 Bergen Parkway, Suite 211 Evergreen, Colorado 80439 General Adult Psychiatry Outpatient and Hospital Care Medical Consultation-Liaison Service Telephone (303) 674-6074

More information

PERINATAL TOBACCO USE

PERINATAL TOBACCO USE PERINATAL TOBACCO USE Child Fatality Task Force Perinatal Health Committee Meeting November 4, 2015 Erin McClain, MA, MPH You Quit, Two Quit, UNC Center for Maternal & Infant Health Percentage Women &

More information

Program Application. Name: SSN: Address: City: State: Zip: Phone: Date of Birth: Age: Occupation: Highest Grade Completed/College/Degree:

Program Application. Name: SSN: Address: City: State: Zip: Phone: Date of Birth: Age: Occupation: Highest Grade Completed/College/Degree: DATE: I. PERSONAL INFORMATION Name: SSN: Address: City: State: Zip: Phone: Date of Birth: Age: Occupation: Highest Grade Completed/College/Degree: Other skills/training: What tools can you use: Farm or

More information

Beyond Birth: A Comprehensive Recovery Center serving parenting women

Beyond Birth: A Comprehensive Recovery Center serving parenting women Beyond Birth: A Comprehensive Recovery Center serving parenting women Session Objectives Highlight Plan of Safe Care Introduce the Beyond Birth Comprehensive Recovery Center Describe Levels of Care The

More information

Pain Medication Management Program Monitors Patient Compliance

Pain Medication Management Program Monitors Patient Compliance PeaceHealth Laboratories UPDATE 2014/15 Edition Pain Medication Management Program Monitors Patient Compliance BENEFITS Monitors analgesic medication adherence to ensure patient safety and protect your

More information

Emergent Issues Affecting Early Intervention/ Early Childhood. Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC

Emergent Issues Affecting Early Intervention/ Early Childhood. Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC Emergent Issues Affecting Early Intervention/ Early Childhood Workforce Development for Inclusion in Early Childhood November 4, 2017 Washington, DC Conversation Points Changing Demographics Emergent Trends

More information

DESCRIPTION OF FOLLOW-UP SAMPLE AT INTAKE SECTION TWO

DESCRIPTION OF FOLLOW-UP SAMPLE AT INTAKE SECTION TWO SECTION TWO DESCRIPTION OF FOLLOW-UP SAMPLE AT INTAKE 7 2.1 DEMOGRAPHIC CHARACTERISTICS Table 2.1 presents demographic descriptive data at intake for those who were included in the follow-up study. Data

More information

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS

A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS A Comprehensive Screening of Illicit and Pain Management Drugs from Whole Blood Using SPE and LC/MS/MS Introduction Drug analysis from whole blood is gaining popularity due to a more complete measurement

More information

INTRODUCTION. Baltimore, Maryland 6 School of Medicine West Virginia University, Morgantown, West Virginia

INTRODUCTION. Baltimore, Maryland 6 School of Medicine West Virginia University, Morgantown, West Virginia The American Journal on Addictions, 27: 92 96, 2018 Copyright 2018 American Academy of Addiction Psychiatry ISSN: 1055-0496 print / 1521-0391 online DOI: 10.1111/ajad.12687 Brief Report: Treating Women

More information